Saba Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Saba Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-756,253	Closed	-$52.7K	–	599
2023 Q3	$52.7K	Hold	756,253	–	–	﹤0.01%	375
2023 Q2	$105K	Hold	756,253	–	–	﹤0.01%	364
2023 Q1	$64.3K	Hold	756,253	–	–	﹤0.01%	521
2022 Q4	$34.8K	Hold	756,253	–	–	﹤0.01%	684
2022 Q3	$109K	Hold	756,253	–	–	﹤0.01%	760
2022 Q2	$83K	Hold	756,253	–	–	﹤0.01%	848
2022 Q1	$170K	Buy	+756,253	New	+$196K	﹤0.01%	756

Saba Capital Management's BIOSW Position: Q4 2023 in Review

Saba Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 756,253 shares — an estimated $52.7K sold.

Saba Capital Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $170K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Saba Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Saba Capital Management sold 756,253 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $52.7K.
Saba Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Saba Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $170K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Saba Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.